Stool speed, not stool size, may be the gut metric that matters most. A new study reports that the time feces spend moving through the intestines tracks closely with markers of metabolic and inflammatory health, suggesting that bowel regularity functions as a rough clinical readout rather than a trivial comfort issue.
Behind this claim sits a simple mechanism. When transit slows, intestinal microbes have longer contact with undigested substrates and bile acids, reshaping microbial composition and the production of short-chain fatty acids and lipopolysaccharides, compounds known to influence systemic inflammation and insulin sensitivity. Researchers found that people with longer transit showed microbiome profiles enriched in bacteria associated with higher C-reactive protein and unfavorable lipid patterns, while faster transit aligned with more diverse communities and metabolites tied to improved gut barrier integrity.
Equally striking is the study’s argument that self-reported stool form, scored on instruments such as the Bristol stool chart, can approximate transit time and, by extension, hint at cardiometabolic risk without blood draws or imaging. That proposition challenges the clinical habit of treating bowel habits as background noise, folding them instead into risk stratification alongside body mass index, blood pressure and fasting glucose, and turning an everyday, often ignored bodily function into a quiet diagnostic signal.
